Literature DB >> 17225931

Association of vascular parkinsonism with impaired neuronal integrity in the striatum.

M Ihara1, H Tomimoto, K Ishizu, H Yoshida, N Sawamoto, K Hashikawa, H Fukuyama.   

Abstract

The purpose of this study is to identify the underlying differences between patients with white matter lesions (WMLs) who manifested gait disturbance suggestive of vascular parkinsonism (VaP) and those who did not, using the PET scan. Fourteen patients with extensive WMLs, as determined by MRI, were divided into two groups - 7 with gait disturbance and 7 without it. Neuronal integrity was evaluated with a PET scan using [(11)C]flumazenil (FMZ) by calculating the distribution volume of FMZ (FMZ-V(d)) in various regions of interest by non-linear curve fitting. Additionally, tracer kinetic analysis was applied for voxel-by-voxel quantification of FMZ-V(d) and data analysis was performed using statistical parametric mapping. The striatal FMZ-V(d) values were inversely correlated with the motor UPDRS scores (r = 0.70, p < 0.005), and their reductions were associated with the presence of gait disturbance. Therefore, differences in neuronal integrity in the striatum may determine whether patients with WMLs develop VaP or not.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17225931     DOI: 10.1007/s00702-006-0610-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  How valid is the clinical diagnosis of Parkinson's disease in the community?

Authors:  K A Jellinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

2.  A JAVA environment for medical image data analysis: initial application for brain PET quantitation.

Authors:  K Mikolajczyk; M Szabatin; P Rudnicki; M Grodzki; C Burger
Journal:  Med Inform (Lond)       Date:  1998 Jul-Sep

Review 3.  Pathological lesions in vascular dementia.

Authors:  Leonardo Pantoni; Vanessa Palumbo; Cristina Sarti
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

4.  Simple analytic method of 11C-flumazenil metabolite in blood.

Authors:  Yasuhiro Magata; Takahiro Mukai; Masafumi Ihara; Sadahiko Nishizawa; Haruhiro Kitano; Koichi Ishizu; Hideo Saji; Junji Konishi
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

Review 5.  [Vascular parkinsonian syndrome].

Authors:  G Ebersbach; W Poewe
Journal:  Nervenarzt       Date:  2006-02       Impact factor: 1.214

6.  Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants.

Authors:  R Schmidt; M Hayn; F Fazekas; P Kapeller; H Esterbauer
Journal:  Stroke       Date:  1996-11       Impact factor: 7.914

7.  Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke.

Authors:  W D Heiss; M Grond; A Thiel; M Ghaemi; J Sobesky; J Rudolf; B Bauer; K Wienhard
Journal:  Stroke       Date:  1998-02       Impact factor: 7.914

8.  Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy.

Authors:  S Gilman; R A Koeppe; L Junck; K J Kluin; M Lohman; R T St Laurent
Journal:  Ann Neurol       Date:  1994-08       Impact factor: 10.422

9.  Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil.

Authors:  V A Holthoff; R A Koeppe; K A Frey; A H Paradise; D E Kuhl
Journal:  J Cereb Blood Flow Metab       Date:  1991-09       Impact factor: 6.200

10.  Clinical correlates of vascular parkinsonism.

Authors:  J Winikates; J Jankovic
Journal:  Arch Neurol       Date:  1999-01
View more
  6 in total

Review 1.  The clinical manifestations and pathophysiology of cerebral small vessel disease.

Authors:  Ai-Juan Zhang; Xin-Jun Yu; Mei Wang
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 2.  Imaging the role of GABA in movement disorders.

Authors:  Henning Boecker
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 5.081

3.  Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Authors:  Charles M Laymon; Rajesh Narendran; Neale S Mason; Jonathan P Carney; Brian J Lopresti; Chester A Mathis; James M Mountz; Donald Sashin; W Gordan Frankle
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

4.  Combining CRISPR-Cas9 and brain imaging to study the link from genes to molecules to networks.

Authors:  Sabina Marciano; Tudor M Ionescu; Ran Sing Saw; Rachel Y Cheong; Deniz Kirik; Andreas Maurer; Bernd J Pichler; Kristina Herfert
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

5.  Low Cerebral Glucose Metabolism: A Potential Predictor for the Severity of Vascular Parkinsonism and Parkinson's Disease.

Authors:  Yunqi Xu; Xiaobo Wei; Xu Liu; Jinchi Liao; Jiaping Lin; Cansheng Zhu; Xiaochun Meng; Dongsi Xie; Dongman Chao; Albert J Fenoy; Muhua Cheng; Beisha Tang; Zhuohua Zhang; Ying Xia; Qing Wang
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

Review 6.  Simultaneous PET/MRI: The future gold standard for characterizing motor neuron disease-A clinico-radiological and neuroscientific perspective.

Authors:  Freimut D Juengling; Frank Wuest; Sanjay Kalra; Federica Agosta; Ralf Schirrmacher; Alexander Thiel; Wolfgang Thaiss; Hans-Peter Müller; Jan Kassubek
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.